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Approximately 30% of patients with Chagas cardiomyopathy (ChC)
develop severe chronic cardiomyopathy, having heart failure (HF) as a
common complication [1]. HF patients usually present dyspnea and
fatigue as symptoms limiting thephysical anddaily life activities [1,2]. The
reduced functional capacity on ChC is associatedwith neurohumoral and
inﬂammatory markers [3] which could improve the respiratory muscle
weakness observed in HF patients.
In this study we compared the respiratory function, muscle strength
and endurance of patients with ChC and patients with HF for other
etiologies as well as the relation with the functional capacity. We
evaluated 45 subjects, 15 in each group of patients (ChC group and HF for
other etiologies—HF group) and 15 healthy subjects (control group). The
inclusion criteriawere: age b 65, no smoking,withoutmusculoskeletal or
other conditions that could compromise exercise tests, no participation
on regular physical activity program from the last six months, without
diabetes mellitus or other metabolic diseases and no use of pacemakers.
For the ChC group, Chagas disease was diagnosed based on the presence
of at least two positive serological tests (ELISA, indirect hemagglutination
or indirect immunoﬂuorescence). Exclusion criteria included the pre-
sence of ventilatory alterations on spirometry, clinical instability or
inability to execute any procedures. The Ethic and Research Committee
approved the study and volunteers signed the informed consent.
Forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1),
FEV1/FVC and 25–75% of expiratory forced ﬂow (FEF25–75%) expressed in
liter (l) and inpercentage (%) of thepredicted value [4]were evaluatedby
standardized pulmonary function tests considering 80% as normal.
Respiratory muscle strength was assessed by the maximal inspiratory
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Table 1
Demographic, anthropometric and ecocardiography data.
Variables Control
(n = 15)
HF
(n = 15)
Ch
(n = 15)
p value
Gender (F:M) 7:8 7:8 7:8 –
Age (year) 47.27 ± 9.12 48.60 ± 8.95 50.27 ± 5.68 0.59
Weight (kg) 64.47
± 12.14
72.87 ± 16.32 64.91 ± 12.91 0.19
Height (m) 1.64 ± 0.08 1.65 ± 0.09 1.61 ± 0.10 0.31
BMI (kg/m2) 23.70
± 3.59
26.93 ± 5.60 24.93 ± 4.03 0.15
NYHA (II:III) – 12:3 13:2 –
LVEF (%)a – 40.00 (30.22–57.38) 36.00 (34.45–2.88) 0.72
LVD (mm)a – 69.00 (62.56–
75.84)
62.00 (59.95–
65.11)
0.07
Data expressed as media and standard deviation or median (interquartile range).
ANOVA and Mann–Whitney Testa.
ChC: Chagas cardiomyopathy, HF: heart failure, F: female, M: male, BMI: body mass
index, NYHA: New York Heart Association, LVEF: left ventricular ejection fraction, LVD:
left ventricular end-diastolic diameter.
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muscle pressure (MIP) and maximal expiratory muscle pressure (MEP),
at residual volume and total lung capacity, respectively, using a
manovacuometer (MTR, GERAR® SP/Brazil) with a conventional mouth-
piece and nose clip [4]. The Threshold® IMT, a device calibrated in
centimeters of water, was used to assess the inspiratory muscle
endurance. Brieﬂy it consisted of breathing during 2 min at 50% of MIP,
and subsequently, 10% of MIP added every 2 min until the subjects
stopped because of fatigue or dyspnea. The greatest pressure sustained
for at least 1 min (maximal peak pressure — Pm-peak) was considered
[5]. The maximal functional capacity, expressed as estimated oxygen
consumption achieved (peak V02), was evaluated by a symptom-
limited exercise test using Bruce protocol.
Normal continuous variables were expressed as mean and standard
deviation (mean ± SD) and nonnormal (Shapiro–Wilk) data as median
and interquartile range. Comparisons were made by ANOVA one-way
plus Tukey test or Kruskal–Wallis plus Wilcoxon and correlations by
Spearman coefﬁcient considering the signiﬁcance level of 0.05.
Table 1 shows the main group characteristics. The HF group was
characterized by 40% of dilated cardiomyopathy and 60% of ischemic
cardiomyopathy. Themain results (Table 2)were: 1) patientswith Chagas
cardiomyopathy presented a reduced respiratory muscle strength and
endurance as well as reduced functional capacity; 2) the respiratory
function, the respiratory muscle strength and endurance and the
functional capacity of these patients were similar to the ones with non-
Chagas cardiomyopathy, except for forced vital capacity (HF b ChC,
p= 0.043) and 3) the ChC group presented reduced chronotropic
response to the same level of exercise compared with the HF group. In
cardiomyopathy patients' peak V02 signiﬁcantly (p b 0.0001) correlated
with the respiratory variables, MIP, MEP and Pm-peak (r = 0.52, 0.53 and
0.55, respectively) but not with the left ventricular function (r =−0.25,
p = 0.22).
This study reinforces hypothesis presented in a previous study
conducted by our group [2] that increased level of circulating proin-
ﬂammatory chemokines could provoke respiratory and limb weakness
and cause reduced physical activity and dyspnea in these patients. Oca
et al. [6] demonstrate more glycolytic and less oxidative capacity of the
peripheral muscle in patients with advanced Chagas disease. These
alterations could be related to the auto-immune process present during
the chronic phase of Chagas disease, whereas the autoimmunity is
considered a pathological mechanism for heart and muscle injuries.
Although reduced values of pulmonary function variables were found,
they are between the clinically normal ranges. The reducedMIP observed
in the patient groups is similar to that in other studieswithHF patients for
differentetiologies [7]. Consideredas an importantparameter to represent
the respiratory effort necessary to daily activities [8], the lowest
respiratory muscle endurance (Pm-peak) in HF and ChC patients was also
reported by previous study [9]. The %MEP lower than 70% of the predicted
value on ChC patients is considered as a reference to prescribe the
respiratory muscle training and could indicate the impairment of the
peripheral muscle.
A reduced peak VO2 and also a characteristic reduced chronotropic
response were observed on ChC patients [1]. The respiratory variables
of cardiomyopathypatients correlatewithVO2ashasbeen identiﬁed inHF
[7]. On the other hand, the absence of correlation between functional
capacity (peak VO2) and LFVE indicates that these phenomena are
different, though related and have different determinants as described by
Lima et al. [10].
A study with ChC patients reported improvement on functional
capacity and quality of life after aerobic training [7]. However, knowledge
about the effect of respiratory muscle training in this population is still
scarce. Other studies have to be conducted including patients with NYHA
III and IV considering that there is a relationship between functional
capacity and severity of ChC [2].
In conclusion, patients with Chagas cardiomyopathy also present a
reduced strength and resistance of respiratory muscles correlated to
functional capacity. These results reinforce the useful strategy to
considerer the evaluation and training of the respiratory muscles in the
clinical management of these patients.
Table 2
Spirometric, respiratory muscle function and symptom-limited exercise test variables.
Variables Control
(n = 15)
HF
(n = 15)
ChC
(n = 15)
p value
FVC (L) 3.68 ± 0.65 3.22 ± 0.98 3.39 ± 0.75 0.30
% previsto 96.2 ± 7.94 83.4 ± 13.45 95.7 ± 17.43 0.02
p = 0.013a p = 0.017b
FEV1 (L) 2.93 ± 0.53 2.55 ± 0.83 2.51 ± 0.57 0.17
% previsto 93.6 ± 9.22 80.5 ± 15.18 87.0 ± 14.93 0.04
p = 0.010a
FEV1/FVC 81.26 ± 5.71 81.33 ± 8.16 77.69 ± 9.34 0.36
% previsto 99.6 ± 6.88 99.0 ± 10.01 95.9 ± 11.25 0.54
FEF25–75% (L/s) 2.60 (2.28–3.38) 2.35 (2.10-3.52) 1.81 (1.60–2.63) 0.12c
% previsto 82.00 (74.56–104.51) 83.00 (63.27–123.11) 68.00 (56.83–87.44) 0.28c
MIP (cmH2O) 80 (73.65–98.35) 50.00 (53.20–73.46) 50.00 (46.70–75.97) 0.01c
p = 0.009a p = 0.02a
% previsto 84.1 ± 21.00 62.3 ± 13.13 60.4 ± 23.32 0.003
p = 0.011a p = 0.005a
MEP (cmH2O) 102.6 ± 43.91 90.0 ± 45.35 73.3 ± 42.28 0.20
% previsto 97.7 ± 43.81 80.1 ± 28.43 68.1 ± 31.55a 0.08
Pm-peak (cmH2O) 72.00 (59.36–83.04) 38.00 (31.35–48.65) 35.00 (34.64–57.90) 0.001c
p b 0.001a p b 0.001a
V02 (mL/kg/min) 38.53 ± 7.81 30.80 ± 9.58 28.46 ± 6.58 0.004
p = 0.032a p = 0.004a
MET 10.64 ± 2.69 8.80 ± 2.73 8.13 ± 1.88 0.023
NS (p = 0.11) p = 0.022a
HRpeak (bpm) 164.5 ± 19.88 147.1 ± 19.50 116.1 ± 14.72 b0.0001
p = 0.032a p b 0.0001a
Data are presented as media and standard deviation or median (interquartile range). NS: no signiﬁcant. Bold: signiﬁcant between groups. ANOVA or Kruskall-Wallis Testc plus post-
hoc Tukey or Wilcoxon.
ChC: Chagas cardiomyopathy, HF: heart failure, FVC: forced vital capacity, FEV1: forced expiratory volume in 1 s, FEF25–75%: 25–75% of expiratory forced ﬂow,MIP: maximal inspiratory
pressure, MEP: maximal expiratory pressure, Pm-peak: maximal peak pressure, V02: peak oxygen consumption, MET: metabolic index, HRpeak: peak heart rate.
a In relation to control group.
b In relation to HF group.
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Acutemyocardial infarction (AMI) following blunt chest trauma (BCT)
is a life-threatening complication of blunt chest trauma [1], the incidence
of this disease will increase with the growth of the population mobility.
How to prevent and decrease the occurrence of this special myocardial
infarction appropriately are not clear due to its infrequent occurrence and
lack of prospective randomized studies and relevant guideline. Theremay
be different etiologies and pathogenesis and preventive in this special
myocardial infarction compared to general myocardial infarction [2]. 122
cases of acute myocardial infarction following blunt chest trauma were
reviewed to provide helps for the prevention of it.
By searching Medline (from 1990 to 2012) for the terms “myocardial
infarction and blunt trauma”, “coronary and blunt trauma”, and
“myocardial ischemia and blunt trauma”, we searched out 116 English
full articles on myocardial infarction resulting from blunt trauma,
involving a total of 122 patients[3].
Among the122 cases,112 cases (91.8%)weremales and10cases (8.2%)
were females, the average age was 36.8 years old, the youngest was
8 years old and the oldest was 68 years old. Among the traumas causing
AMI, 87 cases (71.3%) were road trafﬁc accidents, 16 cases (13.1%) were
sporting accidents in which the patient was hit by a shoulder or a ball or
was kickeddirectly in the chest,10 cases (8.2%) inwhich the patientswere
hit by other objects in the chest or back, 9 cases (7.4%)were other reasons.
Only one patient (0.8%) has a deﬁnite coronary heart disease history, 118
patients (96.7%) have no deﬁnite coronary heart disease histories, no
records were given in 3 cases. 76 patients (62.3%) were accompanied by
various injuries of other organs such as fractures, pulmonary or liver
contusion, pneumothorax, hemothorax, mediastinal emphysema,
mediastinal hematoma, hemopericardium, vitreous hemorrhage,
and injuries of other organs. 36 cases (29.5%) were not
accompanied by important organ injuries, no records were given
in 10 cases (8.2%).
Of the 122 patients, therewere 87 cases of anterior MI and 20 cases of
inferior MI according to electrocardiograph (ECG). Among the 112 cases
with angiographies, 56 cases (50%)were accompanied by obvious intimal
tears or dissections, 20 cases (17.9%) were accompanied by thrombogen-
esis, 4 cases (3.6%) were accompanied by compression of aneurysms.
This literature review shows that 91.8% of patients weremales and the
average age was 36.8 years old in this group of patients, suggesting that
this kind of disease occurs frequently in young males because men are
more often involved in trafﬁc accidents, sports, or ﬁghts. The most
common reason of AMI after BCT was road trafﬁc accidents, the second
commonreasonof itwas sportingaccidents andﬁght, only0.8%ofpatients
has adeﬁnite coronaryheart diseasehistory in this review, suggesting that
there is no evident relation between coronary heart disease and AMI
following BCT.
The exact mechanisms of AMI after BCT is not clear, the heart and the
coronary can be injured by the blood reﬂux and large impact force
resulting from sudden slowdown of inertia effect, AMI could be resulted
from intimal tear, subintimal hemorrhage, plaque rupture, thrombosis,
coronary artery dissection, spasm, rupture, etc. The angiographic ﬁnding
of this group shows that there were various tear, dissection of the intimal
area and medial area of the coronary artery in more than 50% of patients
[4,5], various thrombogenesis in 17.9% of patients [5,6], which suggest
that the injuries to coronary arteries and accompanying thrombogenesis
may be the major mechanisms of AMI following BCT. The most frequent
location involved in AMI after BCT is anterior wall, the second is inferior
wall in this review. In the 112 cases of reported AMI with angiography
following blunt trauma, 60.7% of the infarct-related coronary arteries
were LAD, 14.3% were RCA, and 5.4% were LCX, which resembles to the
earlier report [7]. The higher incidence of LAD involvement may relate to
its proximity to the sternum and vertebral column. Dramatic acceleration
deceleration forces probably cause intimal tears of the most vulnerable
part of the LAD. Two vessels can also be affected [8] simultaneously in this
review. There are normal angiographic ﬁndings [9,10] in 3.6% of patients
of this group suggesting that coronary spasmmay be a cause of some AMI
following BCT.
All of these suggest that increasing awareness of safety, reducing
trafﬁc accidents and taking appropriate protective measures for chest
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